International Journal of Molecular Sciences·Apr 17Human-Specific Organization of Proliferation and Stemness in Squamous Epithelia: A Comparative Study to Elucidate Differences in Stem Cell OrganizationCross-sectional study in peopleMechanismsPaper
Journal of Menopausal Medicine·Sep 24Efficacy and Safety of Intravaginal Estrogen in the Treatment of Atrophic Vaginitis: A Systematic Review and Meta-AnalysisMeta-analysis of randomized trialsEstrogenPaper
Menopause·Jun 1Effects of topical dehydroepiandrosterone therapy in women after pelvic organ prolapse surgeryRandomized trial in 90 peopleInterventionsPaper
Menopause·Oct 11Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 205 women treated with 10 μg estradiol vaginal tabletsStudy in peopleInterventionsPaper
Menopause·Nov 1Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopauseRandomized trial in peopleDyspareuniaPaper
Menopause·Mar 1Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopauseRandomized trial in peopleDyspareuniaPaper
Menopause·Sep 1Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone)Randomized trial in peopleDyspareuniaPaper
Climacteric·Mar 3Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophyRandomized trial in peopleInterventionsPaper
Climacteric·Jan 18Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareuniaRandomized trial in 114 peopleDyspareuniaPaper
Gynecological Endocrinology·Jul 1High internal consistency and efficacy of intravaginal DHEA for vaginal atrophyRandomized trial in 218 peopleVaginal atrophyPaper
Menopause·Jan 1Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophyRandomized trial in 216 peopleVaginal atrophyPaper